Methotrexate for treating rheumatoid arthritis
34 results
1 - 34
Methotrexate for treating rheumatoid arthritis- Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis): Cochrane systematic review
- Methotrexate monotherapy versus methotrexate combination therapy with non‐biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis
- Adalimumab for treating rheumatoid arthritis
- Rituximab for rheumatoid arthritis: Cochrane systematic review
- Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis
- Penicillamine for treating rheumatoid arthritis
- Tocilizumab for rheumatoid arthritis: Cochrane systematic review
- Golimumab for rheumatoid arthritis: Cochrane systematic review
- Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta‐analysis
- Etanercept for the treatment of rheumatoid arthritis: Cochrane systematic review
- Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis
- Cyclophosphamide for treating rheumatoid arthritis
- Methotrexate for psoriatic arthritis
- Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis): Cochrane systematic review
- Infliximab for the treatment of rheumatoid arthritis
- Leflunomide for the treatment of rheumatoid arthritis
- Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease‐modifying anti‐rheumatic drugs: a systematic review and network meta‐analysis
- Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
- Methotrexate for ankylosing spondylitis
- Methotrexate for induction of remission in refractory Crohn's disease: Cochrane systematic review
- Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease‐modifying anti‐rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta‐analysis (NMA)